U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
Related Posts
NAB Raises Dividend Despite a 6.1% Fall in Annual Profit
National Australia Bank raised its dividend despite a 6.1% fall in annual profit on lower lending margins and higher costs.
On Day of Fatal BP Refinery Blast, 3,712 Safety Alarms and One Unsent Email
The company played down worker concerns, missing multiple opportunities to prevent a September 2022 explosion that killed two brothers, government investigators found.
Temu Owner PDD Misses Forecasts as Revenue Growth Slows
The Chinese e-commerce company missed sales and profit expectations, highlighting the growing challenges at home and abroad.